BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Carbonic Anhydrase Iii

Below is an extended Carbonic Anhydrase Iii research listing. Click here to return to the Carbonic Anhydrase Iii main in depth entry.

Recent Publications on Carbonic Anhydrase Iii:

Carbonic anhydrase activators: Activation of the human cytosolic isozyme III and membrane-associated isoform IV with amino acids and amines.
An activation study of the human carbonic anhydrase (hCA, EC 4.2.1.1)...
Direct Link
23rd August, 2008
Universita degli Studi di Firenze, Laboratorio di Chimica Bioinorganica,
A novel renal carbonic anhydrase type III plays a role in proximal tubule dysfunction.
Dysfunction of the proximal tubule (PT) is associated with variable...
Direct Link
31st July, 2008
Division of Cell Physiology, Christian de Duve Institute of Cellular
Influence of acute physical exercise on emerging muscular biomarkers.
Abstract Background: Although there is comprehensive information on...
Direct Link
19th July, 2008
1Sezione di Chimica Clinica, Dipartimento di Scienze
Carbonic Anhydrase III and Four-and-a-Half LIM Protein 1 are preferentially oxidized with muscle unloading.
The identities of proteins that show disuse-related changes in the content...
Direct Link
27th May, 2008
University of Minnesota.
Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with some 1,3,4-oxadiazole- and 1,2,4-triazole-thiols.
Novel mercapto-1,3,4-oxadiazole and -1,2,4-triazole derivatives were...
Direct Link
22nd May, 2008
Organic Chemistry Department, Faculty of Pharmacy, Traian Vuia Street 6,
Characterizing the lipid-lowering effects and antioxidant mechanisms of tomato paste. 10th May, 2008
Department of Biological Science and Technology, China Medical University,
Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway.
Carbonic anhydrase III (CAIII) is distinguished from the other members of...
Direct Link
30th April, 2008
Graduate Institute of Life Sciences, National Defense Medical Center,
Expression pattern and polymorphism of three microsatellite markers in the porcine CA3 gene.
Carbonic anhydrase III (CA3) is an abundant muscle protein characteristic...
Direct Link
27th February, 2008
Department of Basic Veterinary Medicine, College of Veterinary Medicine,
Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology.
OBJECTIVES: The analytical and clinical performance of the Evidence...
Direct Link
6th February, 2008
Department of Laboratory Medicine, University-Hospital of Padova, Via
Advanced glycation end-product accumulation and associated protein modification in type II skeletal muscle with aging. 25th January, 2008
Department of Physical Medicine and Rehabilitation, University of
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
The cytosolic human carbonic anhydrase (hCA, EC 4.2.1.1) isozyme III (hCA...
Direct Link
12th January, 2008
Department of Gastroenterology and Hepatology, Kochi Medical School,
A new target for autoantibodies in patients with rheumatoid arthritis. 31st October, 2007
Hospices Civils de Lyon, INSERM U851, Lyon-Sud Hospital, Department of
Carbonic anhydrase III: a new target for autoantibodies in autoimmune diseases.
The objective of this study was to identify new autoantibodies that could...
Direct Link
24th October, 2007
Department of Autoimmunity, Lyon-Sud Hospital, Hospices Civils de Lyon,
Identification by proteomic tool of atypical anti-liver/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantation.
De novo autoimmune hepatitis (AIH) occurs after liver transplantation for...
Direct Link
3rd October, 2007
INSERM, Unite 785, Villejuif, F-94804, France.
Exercise training in normobaric hypoxia: is carbonic anhydrase III the best marker of hypoxia?
De novo autoimmune hepatitis (AIH) occurs after liver transplantation for...
Direct Link
21st September, 2007
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional